US FDA approves Pfizer's drug for rare bleeding disorder
11/10/2024 18:24
Oct 11 (Reuters) - The U.S. Food and Drug Administration
approved Pfizer's PFE.N once-a-week injection for the two main
types of a rare bleeding disorder called hemophilia, the company
said on Friday.
(Reporting by Sruthi Narasimha Chari and Christy Santhosh in
Bengaluru; Editing by Vijay Kishore)
((SruthiNarasimha.Chari@thomsonreuters.com))